These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 31189228)

  • 1. [Blood eosinophils: a biomarker of response to glucocorticoids and increased readmissions in severe hospitalized exacerbations of COPD].
    Xue J; Cui YN; Chen P; Cai S; Chen L; Dai ZS; Chen Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2019 Jun; 42(6):426-431. PubMed ID: 31189228
    [No Abstract]   [Full Text] [Related]  

  • 2. Eosinophil counts in first COPD hospitalizations: a comparison of health service utilization.
    Bélanger M; Couillard S; Courteau J; Larivée P; Poder TG; Carrier N; Girard K; Vézina FA; Vanasse A
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3045-3054. PubMed ID: 30319252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eosinophils in COPD Exacerbations Are Associated With Increased Readmissions.
    Couillard S; Larivée P; Courteau J; Vanasse A
    Chest; 2017 Feb; 151(2):366-373. PubMed ID: 27746201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical investigation on the related factors for the application of systemic glucocorticoids in patients with acute exacerbation of chronic obstructive pulmonary disease with carbon dioxide retention].
    Jiao W; Zhang W; Zhang C; Liu Z; Gan Y; Peng Z; Yan G; Deng X; Xue Q; Wu J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Sep; 32(9):1061-1066. PubMed ID: 33081891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The utility of inflammatory markers to predict readmissions and mortality in COPD cases with or without eosinophilia.
    Duman D; Aksoy E; Agca MC; Kocak ND; Ozmen I; Akturk UA; Gungor S; Tepetam FM; Eroglu SA; Oztas S; Karakurt Z
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2469-78. PubMed ID: 26648709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood Eosinophil Levels and Prognosis of Hospitalized Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Yu S; Zhang J; Fang Q; Tong Z
    Am J Med Sci; 2021 Jul; 362(1):56-62. PubMed ID: 33617785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of Blood Eosinophils in COPD with Multiple Acute Exacerbations Within 1 Year and Its Relationship with Prognosis.
    Gong Y; Sun H
    Int J Chron Obstruct Pulmon Dis; 2022; 17():3123-3128. PubMed ID: 36582652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Value of Neutrophil to Lymphocyte Ratio for Predicting 90-Day Poor Outcomes in Hospitalized Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Feng X; Xiao H; Duan Y; Li Q; Ou X
    Int J Chron Obstruct Pulmon Dis; 2023; 18():1219-1230. PubMed ID: 37337582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of 12-Month Readmission for Hospitalized Patients with COPD: A Propensity Score Matched Analysis of Prospective Multicenter Study.
    Xu T; Sun W; Zhao H; Wang X; Yuan Q; Zhang X; Mao S; Zhang X; Zhao M; Sheng Z; Zhang M; Huang M; Ji N
    Int J Chron Obstruct Pulmon Dis; 2022; 17():2329-2341. PubMed ID: 36164549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood eosinophils and treatment response in hospitalized exacerbations of chronic obstructive pulmonary disease: A case-control study.
    Serafino-Agrusa L; Scichilone N; Spatafora M; Battaglia S
    Pulm Pharmacol Ther; 2016 Apr; 37():89-94. PubMed ID: 26996272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Blood Eosinophil and YKL-40 Levels, as Well as Low CXCL9 Levels, are Associated with Increased Readmission in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Peng J; Yu Q; Fan S; Chen X; Tang R; Wang D; Qi D
    Int J Chron Obstruct Pulmon Dis; 2021; 16():795-806. PubMed ID: 33814903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multi-center randomized, controlled, open-label trial evaluating the effects of eosinophil-guided corticosteroid-sparing therapy in hospitalised patients with COPD exacerbations - The CORTICO steroid reduction in COPD (CORTICO-COP) study protocol.
    Sivapalan P; Moberg M; Eklöf J; Janner J; Vestbo J; Laub RR; Browatzki A; Armbruster K; Wilcke JT; Seersholm N; Weinreich UM; Titlestad IL; Andreassen HF; Ulrik CS; Bødtger U; Nielsen TL; Hansen EF; Jensen JUS
    BMC Pulm Med; 2017 Aug; 17(1):114. PubMed ID: 28810909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevalence and clinical characteristics of blood eosinophilia in patients with acute exacerbation of chronic obstructive pulmonary disease].
    Zeng QL; Wang XM; Li SN; Xiong B; Jian M; Huang G; Wu YQ; Wang XH; Li J; Wen FQ; Zhou H
    Zhonghua Yi Xue Za Zhi; 2017 Oct; 97(40):3166-3170. PubMed ID: 29081164
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical features and three-year prognosis of AECOPD patients with different levels of blood eosinophils.
    Ruiying W; Zhaoyun ; Jianying X
    Heart Lung; 2022; 56():29-39. PubMed ID: 35687923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood Eosinophil Count and Hospital Readmission in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Hegewald MJ; Horne BD; Trudo F; Kreindler JL; Chung Y; Rea S; Blagev DP
    Int J Chron Obstruct Pulmon Dis; 2020; 15():2629-2641. PubMed ID: 33122901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The lower the eosinophils, the stronger the inflammatory response? The relationship of different levels of eosinophils with the degree of inflammation in acute exacerbation chronic obstructive pulmonary disease (AECOPD).
    Lv MY; Qiang LX; Li ZH; Jin SD
    J Thorac Dis; 2021 Jan; 13(1):232-243. PubMed ID: 33569203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of peripheral eosinophilia in acute exacerbation of chronic obstructive pulmonary disease.
    Wu CW; Lan CC; Hsieh PC; Tzeng IS; Wu YK
    World J Clin Cases; 2020 Jul; 8(13):2727-2737. PubMed ID: 32742983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Empirical Glucocorticoid Use on Severe Acute Exacerbation of COPD During Hospitalization.
    Wu L; Lan N; Yang X
    Int J Chron Obstruct Pulmon Dis; 2021; 16():2419-2431. PubMed ID: 34471349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood Eosinophilia and Its Stability in Hospitalized COPD Exacerbations are Associated with Lower Risk of All-Cause Mortality.
    Zhang Y; Liang LR; Zhang S; Lu Y; Chen YY; Shi HZ; Lin YX
    Int J Chron Obstruct Pulmon Dis; 2020; 15():1123-1134. PubMed ID: 32547000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eosinophilic and non-eosinophilic COPD patients with chronic respiratory failure: neutrophil-to-lymphocyte ratio as an exacerbation marker.
    Acartürk Tunçay E; Karakurt Z; Aksoy E; Saltürk C; Gungor S; Ciftaslan N; Irmak İ; Yavuz D; Ocakli B; Adıgüzel N
    Int J Chron Obstruct Pulmon Dis; 2017; 12():3361-3370. PubMed ID: 29200843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.